ClinicalTrials.Veeva

Menu

Vibrotactile Coordinated Reset (VCR): A Treatment for Early Stage Parkinson's Disease

Stanford University logo

Stanford University

Status

Not yet enrolling

Conditions

Parkinson Disease

Treatments

Device: Vibrotactile coordinated reset

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on early stage Parkinson's symptoms. VCR will be administered with a device called the Stanford Glove. vCR is expected to provide patients with a non-invasive alternative to the most widely used treatments such as levodopa and or deep brain stimulation. Patients will be followed for two years.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 92 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Ages 18 and older
  2. Idiopathic Parkinson's disease Hoehn and Yahr stage I
  3. Fluent in English
  4. Appropriate social support if required during an off state.
  5. Comfortable with technology; can use a computer, check email, and access the internet; can initiate and engage in a virtual meeting for training and monitoring purposes.
  6. Feels comfortable going off PD related medication during in person study visits
  7. Lives in the United States

Exclusion criteria

  1. Any significant neuro-psychiatric problems, including acute confusional state, ongoing psychosis, or suicidal tendencies
  2. Any current drug or alcohol abuse.
  3. Participation in another drug, device, or biologics trial concurrently or within the preceding 30 days. Any other trial participation should be approved by the Principal Investigators.
  4. Pregnancy, breast-feeding or wanting to become pregnant
  5. Physical limitations unrelated to PD that would affect motor ratings
  6. Craniotomy
  7. Brain surgery
  8. Patient is unable to communicate properly with staff (i.e., severe speech problems)
  9. Excessive drooling
  10. A type of hair style that would impede the use of an EEG cap
  11. Sensory abnormalities of the fingertips
  12. Nasal dysfunction unrelated to smell loss

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Vibrotactile Coordinated Reset (vCR)
Experimental group
Description:
Vibrotactile Coordinated Reset delivers vibratory stimulation to the fingertips of each hand. A specific pattern of vibration to each fingertip is delivered which theoretically disrupts abnormal synchrony in the brain.
Treatment:
Device: Vibrotactile coordinated reset

Trial contacts and locations

1

Loading...

Central trial contact

Jessica Yankulova; Ellyn Daly

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems